Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
32,470,413
-
Shares change
-
-1,053,746
-
Total reported value, excl. options
-
$295,787,573
-
Value change
-
-$27,220,088
-
Put/Call ratio
-
60%
-
Number of buys
-
52
-
Number of sells
-
-59
-
Price
-
$9.16
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q4 2021
150 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q4 2021.
Altimmune, Inc. - Common Stock (ALT) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,470,413 shares
of 80,702,987 outstanding shares and own 40.23% of the company stock.
Largest 10 shareholders include STATE STREET CORP (4,421,541 shares), BlackRock Inc. (2,956,267 shares), Avidity Partners Management LP (2,765,000 shares), Nuveen Asset Management, LLC (2,295,832 shares), VANGUARD GROUP INC (1,733,755 shares), TANG CAPITAL MANAGEMENT LLC (1,600,000 shares), SPHERA FUNDS MANAGEMENT LTD. (1,244,241 shares), D. E. Shaw & Co., Inc. (1,181,237 shares), MORGAN STANLEY (1,152,254 shares), and BARCLAYS PLC (1,095,060 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.